文献速递瓣膜病与结构性心脏病

合并症负担与经导管主动脉瓣植入术后临床结局的关联

Association of comorbid burden with clinical outcomes after transcatheter aortic valve implantation.
PubMed 文献 · Heart · 2018-07-20

本研究纳入2007至2016年英国、加拿大、西班牙、瑞士和意大利的1887例TAVI患者,分析Charlson合并症指数(CCI)与术后结局的关联。结果显示60%患者CCI≥3,CCI与四种术前风险评分仅弱相关,每单位CCI增加与长期死亡风险升高相关(HR 1.10,95%CI 1.05-1.16),但与30天死亡率、VARC-2早期安全复合终点及住院时长无显著关联。

要点

  • TAVI患者合并症负担重,60%患者CCI≥3。
  • CCI与常用术前风险评分仅弱相关(ρ=0.16-0.29)。
  • CCI每增加1单位与长期死亡风险升高10%相关。

核心结论

  • 在TAVI患者中,CCI与长期死亡率存在中度关联,但与30天死亡率、VARC-2早期安全复合终点及住院时长无关。

研究设计与样本

  • 多中心国际回顾性队列研究,纳入2007至2016年英国、加拿大、西班牙、瑞士和意大利的1887例TAVI患者。
  • 采用 logistic 回归和 Cox 比例风险模型,并在整体队列和国家层面通过两阶段个体参与者数据随机效应 Meta 分析评估关联。

主要发现

  • 60%的患者CCI≥3。
  • 总CCI与四种术前风险评分弱相关(ρ=0.16至0.29),约50%被四种风险预测模型归为低风险的患者仍存在CCI≥3。
  • CCI每增加1单位与30天死亡率(OR 1.09,95%CI 0.96-1.24)和VARC-2早期安全复合终点(OR 1.04,95%CI 0.96-1.14)的比值比无显著关联。
  • CCI每增加1单位与长期死亡率风险升高相关(HR 1.10,95%CI 1.05-1.16)。
  • 两阶段IPD Meta分析显示CCI与住院时长无关(HR 0.97,95%CI 0.93-1.02)。

临床怎么用

  • TAVI术前应评估合并症负担,CCI有助于识别长期死亡风险较高的患者。
  • 常用术前风险评分可能低估合并症负担,低风险评分患者仍可能CCI≥3。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the association of the CharlsonComorbidity Index (CCI) with clinical outcomes after transcatheter aortic valve implantation (TAVI). BACKGROUND: Patients undergoing TAVI have high comorbid burden; however, there is limited evidence of its impact on clinical outcomes. METHODS: Data from 1887 patients from the UK, Canada, Spain, Switzerland and Italy were collected between 2007 and 2016. The association of CCI with 30-day mortality, Valve Academic Research Consortium-2 (VARC-2) composite early safety, long-term survival and length of stay (LoS) was calculated using logistic regression and Cox proportional hazard models, as a whole cohort and at a country level, through a two-stage individual participant data (IPD) random effect meta-analysis. RESULTS: Most (60%) of patients had a CCI ≥3. A weak correlation was found between the total CCI and four different preoperative risks scores (ρ=0.16 to 0.29), and approximately 50% of patients classed as low risk from four risk prediction models still presented with a CCI ≥3. Per-unit increases in total CCI were not associated with increased odds of 30-day mortality (OR 1.09, 95% CI 0.96 to 1.24) or VARC-2 early safety (OR 1.04, 95% CI 0.96 to 1.14) but were associated with increased hazard of long-term mortality (HR 1.10, 95% CI 1.05 to 1.16). The two-stage IPD meta-analysis indicated that CCI was not associated with LoS (HR 0.97, 95% CI 0.93 to 1.02). CONCLUSION: In this multicentre international study, patients undergoing TAVI had significant comorbid burden. We found a weak correlation between the CCI and well-established preoperative risks scores. The CCI had a moderate association with long-term mortality up to 5 years post-TAVI.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Bagur R, Martin GP, Nombela-Franco L, et al. Association of comorbid burden with clinical outcomes after transcatheter aortic valve implantation. Heart. 2018. PMID: 30030336. doi:10.1136/heartjnl-2018-313356

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。